These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 26303970)
1. Epigenetic silencing of olfactomedin-4 enhances gastric cancer cell invasion via activation of focal adhesion kinase signaling. Guo LL; He ZC; Yang CQ; Qiao PT; Yin GL BMB Rep; 2015 Nov; 48(11):630-5. PubMed ID: 26303970 [TBL] [Abstract][Full Text] [Related]
2. Silencing profilin-1 inhibits gastric cancer progression via integrin β1/focal adhesion kinase pathway modulation. Cheng YJ; Zhu ZX; Zhou JS; Hu ZQ; Zhang JP; Cai QP; Wang LH World J Gastroenterol; 2015 Feb; 21(8):2323-35. PubMed ID: 25741138 [TBL] [Abstract][Full Text] [Related]
3. PTEN inhibits the invasion and metastasis of gastric cancer via downregulation of FAK expression. Zhang LL; Liu J; Lei S; Zhang J; Zhou W; Yu HG Cell Signal; 2014 May; 26(5):1011-20. PubMed ID: 24486402 [TBL] [Abstract][Full Text] [Related]
4. OLFM4 is associated with lymph node metastasis and poor prognosis in patients with gastric cancer. Luo Z; Zhang Q; Zhao Z; Li B; Chen J; Wang Y J Cancer Res Clin Oncol; 2011 Nov; 137(11):1713-20. PubMed ID: 21904905 [TBL] [Abstract][Full Text] [Related]
5. Secreted LOXL2 is a novel therapeutic target that promotes gastric cancer metastasis via the Src/FAK pathway. Peng L; Ran YL; Hu H; Yu L; Liu Q; Zhou Z; Sun YM; Sun LC; Pan J; Sun LX; Zhao P; Yang ZH Carcinogenesis; 2009 Oct; 30(10):1660-9. PubMed ID: 19625348 [TBL] [Abstract][Full Text] [Related]
6. Olfactomedin 4 downregulation is associated with tumor initiation, growth and progression in human prostate cancer. Li H; Kim C; Liu W; Zhu J; Chin K; Rodriguez-Canales J; Rodgers GP Int J Cancer; 2020 Mar; 146(5):1346-1358. PubMed ID: 31241767 [TBL] [Abstract][Full Text] [Related]
7. Depletion of OLFM4 gene inhibits cell growth and increases sensitization to hydrogen peroxide and tumor necrosis factor-alpha induced-apoptosis in gastric cancer cells. Liu RH; Yang MH; Xiang H; Bao LM; Yang HA; Yue LW; Jiang X; Ang N; Wu LY; Huang Y J Biomed Sci; 2012 Apr; 19(1):38. PubMed ID: 22471589 [TBL] [Abstract][Full Text] [Related]
8. Focal adhesion kinase (FAK) gene amplification and its clinical implications in gastric cancer. Park JH; Lee BL; Yoon J; Kim J; Kim MA; Yang HK; Kim WH Hum Pathol; 2010 Dec; 41(12):1664-73. PubMed ID: 20869748 [TBL] [Abstract][Full Text] [Related]
9. Olfactomedin-4 in digestive diseases: A mini-review. Wang XY; Chen SH; Zhang YN; Xu CF World J Gastroenterol; 2018 May; 24(17):1881-1887. PubMed ID: 29740203 [TBL] [Abstract][Full Text] [Related]
10. Maternal embryonic leucine zipper kinase enhances gastric cancer progression via the FAK/Paxillin pathway. Du T; Qu Y; Li J; Li H; Su L; Zhou Q; Yan M; Li C; Zhu Z; Liu B Mol Cancer; 2014 May; 13():100. PubMed ID: 24885567 [TBL] [Abstract][Full Text] [Related]
11. A quantitative proteomics study on olfactomedin 4 in the development of gastric cancer. Ran X; Xu X; Yang Y; She S; Yang M; Li S; Peng H; Ding X; Hu H; Hu P; Zhang D; Ren H; Wu L; Zeng W Int J Oncol; 2015 Nov; 47(5):1932-44. PubMed ID: 26398045 [TBL] [Abstract][Full Text] [Related]
12. OLFM4 Inhibits Epithelial-Mesenchymal Transition and Metastatic Potential of Cervical Cancer Cells. Li J; Liu C; Li D; Wan M; Zhang H; Zheng X; Jie X; Zhang P; Li J; Hou H; Sun Q Oncol Res; 2019 Jul; 27(7):763-771. PubMed ID: 30764901 [TBL] [Abstract][Full Text] [Related]
13. Oestrogen receptor-mediated expression of Olfactomedin 4 regulates the progression of endometrial adenocarcinoma. Duan C; Liu X; Liang S; Yang Z; Xia M; Wang L; Chen S; Yu L J Cell Mol Med; 2014 May; 18(5):863-74. PubMed ID: 24495253 [TBL] [Abstract][Full Text] [Related]
14. Activation of focal adhesion kinase enhances the adhesion and invasion of pancreatic cancer cells via extracellular signal-regulated kinase-1/2 signaling pathway activation. Sawai H; Okada Y; Funahashi H; Matsuo Y; Takahashi H; Takeyama H; Manabe T Mol Cancer; 2005 Oct; 4():37. PubMed ID: 16209712 [TBL] [Abstract][Full Text] [Related]
15. miR-103 regulates triple negative breast cancer cells migration and invasion through targeting olfactomedin 4. Xiong B; Lei X; Zhang L; Fu J Biomed Pharmacother; 2017 May; 89():1401-1408. PubMed ID: 28320108 [TBL] [Abstract][Full Text] [Related]
16. Focal adhesion kinase-related proline-rich tyrosine kinase 2 and focal adhesion kinase are co-overexpressed in early-stage and invasive ErbB-2-positive breast cancer and cooperate for breast cancer cell tumorigenesis and invasiveness. Behmoaram E; Bijian K; Jie S; Xu Y; Darnel A; Bismar TA; Alaoui-Jamali MA Am J Pathol; 2008 Nov; 173(5):1540-50. PubMed ID: 18832579 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA-379 inhibits metastasis and epithelial-mesenchymal transition via targeting FAK/AKT signaling in gastric cancer. Xu M; Qin S; Cao F; Ding S; Li M Int J Oncol; 2017 Sep; 51(3):867-876. PubMed ID: 28713929 [TBL] [Abstract][Full Text] [Related]
18. Capn4 contributes to tumor invasion and metastasis in clear cell renal cell carcinoma cells via modulating talin-focal adhesion kinase signaling pathway. Zhuang Q; Luo W; Zhang M; Fan M; Lu H; Xu R; He X Acta Biochim Biophys Sin (Shanghai); 2018 May; 50(5):465-472. PubMed ID: 29648579 [TBL] [Abstract][Full Text] [Related]
19. NAIF1 inhibits gastric cancer cells migration and invasion via the MAPK pathways. Yang M; Gu YY; Peng H; Zhao M; Wang J; Huang SK; Yuan XH; Li J; Sang JL; Luo Q; Huang C J Cancer Res Clin Oncol; 2015 Jun; 141(6):1037-47. PubMed ID: 25432142 [TBL] [Abstract][Full Text] [Related]
20. Knockdown of FAK inhibits the invasion and metastasis of Tca‑8113 cells in vitro. Xiao W; Jiang M; Li H; Li C; Su R; Huang K Mol Med Rep; 2013 Aug; 8(2):703-7. PubMed ID: 23807215 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]